Editorial

It is with a sense of satisfaction that I introduce volume 4 issue 2 of Pharmacognosy Communications. This issue completes our first 3 years of publication. As Thomson Reuters requires a minimum of 3 years of publication to calculate an impact factor, we have now reached this point and can expect to receive an evaluation and the corresponding impact factor when the next year’s citation statistics are published. This will be a major step forward for Pharmacognosy Communications and will allow us to be compared to other similar publications. I am confident that we will receive a credible first impact factor. Due to the nature of the impact factor calculation, this would be expected to then steadily increase over the following years as the journal builds a more extensive body of previous publications (all of which count towards a journals citable publications). With this step, we can expect Pharmacognosy Communications to continue to develop and improve our reputation in this scientific discipline.